A Postmarket Surveillance Registry of the BioMatrix Drug-eluting Stent
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 31 Oct 2014
At a glance
- Drugs Umirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms eBMX-PMS
- Sponsors Biosensors International Group
- 21 May 2013 New registry data were presented at EuroPCR 2013, according to a Biosensors International Group.
- 20 May 2011 Results have been presented for the first time at EuroPCR-2011 according to a Biosensors International Group media release; results were also reported in the media release.
- 14 Dec 2010 New trial record